- The free zone witnessed a surge of over 11% in its customer base across the sector
Dubai, United Arab Emirates: DP World’s leading trade and logistics hub, Jebel Ali Free Zone’s (Jafza) solidified healthcare & pharmaceuticals businesses, facilitating 47 per cent of Dubai’s trade in 2020. The AED 21.8 billion trade generated by the free zone added much value to the economy of the emirate and the country. In 2021, the free zone also witnessed a 11 per cent year-on-year increase in its healthcare & pharmaceuticals customer base.
At Arab Health 2022, Jafza will showcase its dynamic business model, underpinned by its ‘strategic pillars’ to stimulate the healthcare & pharmaceuticals cluster in Jafza, which comprises over 400 companies from 59 countries. More than 10 per cent manufacture medicine, personal care products, pharmaceutical packaging, medical kits, hygiene products, etc., while 90 per cent are engaged in trading, storage and movement of goods.
Indigenous Manufacturing
As the only free zone that supports indigenous manufacturing for healthcare and pharmaceuticals, it offers an ideal business environment for manufacturing facilities and R&D centres of pharmaceutical and medical equipment companies. Currently, its world-class services and infrastructure are aiding manufacturers like LIFEPharma, Gulf Inject, Quest Vitamins, Vieco Pharmaceuticals, MicroSynergy Pharmaceuticals, Azure industries, Ageback Bio-factory, etc.
Incentives for Business Growth
Its trade accelerators, business incubators, partnerships with financial institutions to help companies secure credit insurance and funding are benefitting countless international healthcare & pharmaceuticals companies and promising SMEs. Availability of pharmaceutical-grade custom-built warehouses, plots and office spaces spread over an area of more than 540,000 sqm and fringe benefits like zero VAT and no customs duties on export, import and re-export have also been a boon.
Multimodal Connectivity
Complementing Jafza’s cutting-edge infrastructure is the unprecedented multimodal connectivity through the Jebel Ali Port that offers access to over 3.5 billion consumers and help healthcare & pharmaceuticals businesses reach countries in the GCC, Indian Subcontinent and Africa. Additionally, Jebel Ali Port’s nearly 10,000 reefer points power refrigerated containers to support businesses adhering to stringent storage regulations.
Logistical Support
“DP World Logistics” supply chain management services ensure that wherever the destination of your products might be, the goods will reach efficiently and cost-effectively. The logistical arm of the trade enabler aims to bolster the reach and growth of healthcare & pharmaceuticals businesses by ensuring timely delivery of both temperature-controlled and general medical cargo using high-end IT platforms.
Digital Trading Solutions
To ensure continued growth for its pharma partners, Jafza gives businesses full access to the global supply chain and utmost transparency through the premier trade facilitation platform, Dubai Trade. The integrated platform has eased cross border pharmaceutical and healthcare trade, by offering e-services from various trade and logistics service providers under a unified window.
-Ends-
© Press Release 2022
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
